Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)
21.43 +1.72 (+8.73%) 14:56 ET [NASDAQ]
21.32 x 200 21.33 x 400
Realtime by (Cboe BZX)
21.32 x 200 21.33 x 400
Realtime 20.06 +0.35 (+1.78%) 09:29 ET
Quote Overview for Thu, Jan 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
19.82
Day High
21.65
Open 20.05
Previous Close 19.71 19.71
Volume 2,409,066 2,409,066
Avg Vol 1,415,032 1,415,032
Stochastic %K 74.19% 74.19%
Weighted Alpha -42.98 -42.98
5-Day Change +2.39 (+12.63%) +2.39 (+12.63%)
52-Week Range 17.05 - 36.72 17.05 - 36.72
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,452,594
  • Shares Outstanding, K 124,434
  • Annual Sales, $ 3,550 K
  • Annual Income, $ -599,490 K
  • EBIT $ -601 M
  • EBITDA $ -586 M
  • 60-Month Beta 0.97
  • Price/Sales 692.43
  • Price/Cash Flow N/A
  • Price/Book 12.86

Options Overview Details

View History
  • Implied Volatility 54.98% ( +6.74%)
  • Historical Volatility 54.11%
  • IV Percentile 20%
  • IV Rank 46.31%
  • IV High 86.91% on 02/29/24
  • IV Low 27.43% on 09/20/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 855
  • Volume Avg (30-Day) 629
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 15,496
  • Open Int (30-Day) 17,062

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.42
  • Number of Estimates 7
  • High Estimate 2.91
  • Low Estimate -1.23
  • Prior Year -1.24
  • Growth Rate Est. (year over year) +66.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.75 +20.11%
on 01/13/25
Period Open: 19.75
21.65 -1.52%
on 01/23/25
+1.57 (+7.95%)
since 12/23/24
3-Month
17.75 +20.11%
on 01/13/25
Period Open: 19.92
27.34 -22.02%
on 11/29/24
+1.40 (+7.03%)
since 10/23/24
52-Week
17.05 +25.04%
on 10/10/24
Period Open: 34.29
36.72 -41.94%
on 03/04/24
-12.97 (-37.82%)
since 01/23/24

Most Recent Stories

More News
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 21.43 (+8.73%)
SRPT : 119.20 (+2.68%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 21.43 (+8.73%)
SRPT : 119.20 (+2.68%)
IJH : 65.42 (-0.09%)
VTI : 301.29 (+0.23%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 21.43 (+8.73%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 21.43 (+8.73%)
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 21.43 (+8.73%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 21.43 (+8.73%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 21.43 (+8.73%)
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...

ARWR : 21.43 (+8.73%)
UPS, Packaging Corp. fall, Arrowhead, Tenet rise

Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise

THC : 137.47 (+2.27%)
JBLU : 8.03 (+2.03%)
CNC : 64.71 (+1.86%)
ARWR : 21.43 (+8.73%)
UPS : 133.40 (+0.64%)
PEP : 148.57 (+0.32%)
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.

AMGN : 276.61 (+1.16%)
GSK : 34.00 (+1.71%)
TAK : 12.93 (+0.31%)
ARWR : 21.43 (+8.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 20.63
2nd Resistance Point 20.32
1st Resistance Point 20.02
Last Price 21.43
1st Support Level 19.41
2nd Support Level 19.10
3rd Support Level 18.80

See More

52-Week High 36.72
Fibonacci 61.8% 29.21
Fibonacci 50% 26.89
Fibonacci 38.2% 24.56
Last Price 21.43
52-Week Low 17.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar